Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
Mechanism of Action of Aminosalicylates
Drugs used in IBD and biological and immune therapy of IBD ” - ppt download
Classical and recent advances in the treatment of inflammatory bowel diseases - Brazilian Journal of Medical and Biological Research
Pharmacogenomics in the treatment of inflammatory bowel disease | Pharmacogenomics
A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug | SpringerLink
GLPs as novel therapeutic options in IBD-potential mechanisms of action | Download Scientific Diagram
Inflammatory Bowel Disease | NEJM
Promising biological therapies for ulcerative colitis: A review of the literature
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
5-ASA | IBD Clinic
The long journey of salicylates in ulcerative colitis: The past and the future - ScienceDirect
Frontiers | Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice | Immunology
Mesalamine | C7H7NO3 - PubChem
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD. - ppt download
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Prof. Hanan Hagar Pharmacology Unit College of Medicine - ppt download
